George K. Ng - 24 Jul 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A - Amendment
Accepted by SEC
18 Sep 2025, 16:21:16 UTC
Original report date
28 Jul 2025
Prior SEC filing
18 Feb 2025
Next SEC filing
03 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ George Ng, by John J. Wolfel, as Attorney-in-Fact

Key filing fact

George K. Ng filed Form 4/A - Amendment for Processa Pharmaceuticals, Inc. (PCSA) on 18 Sep 2025.

Key facts

  • This page summarizes George K. Ng's Form 4/A - Amendment filing for Processa Pharmaceuticals, Inc. (PCSA).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 18 Sep 2025, 16:21.

Change

  • Previous filing in this sequence was filed on 18 Feb 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001638744 Primary reporting owner

Ng George K

Relationship
Chief Executive Officer, Director
Address
C/O PROCESSA PHARMACEUTICALS, INC., 601 21ST STREET SUITE 300, VERO BEACH
Signature
/s/ George Ng, by John J. Wolfel, as Attorney-in-Fact
Signature date
18 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCSA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
87,200
Date
24 Jul 2025
Ownership
George Ng IRRA FBO: George Ng
PCSA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
20,000
Date
24 Jul 2025
Ownership
Ng Cha Family Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCSA holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
87,200
Date
24 Jul 2025
Ownership
George Ng IRRA FBO: George Ng
Underlying class
Common Stock
Underlying amount
87,200
Exercise price
$0.6500
PCSA holding Derivative

Warrants

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
43,600
Date
24 Jul 2025
Ownership
George Ng IRRA FBO: George Ng
Underlying class
Common Stock
Underlying amount
43,600
Exercise price
$0.6500
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

Amendment filed to retract the prior Form 4, which was filed in error.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .